TY - JOUR
T1 - Magnetic resonance imaging–guided renal biopsy shows high safety and diagnostic yield
T2 - a tertiary cancer center experience
AU - Abdelsalam, Mohamed E.
AU - Lu, Thomas
AU - Baiomy, Ali
AU - Awad, Ahmed
AU - Odisio, Bruno C.
AU - Habibollahi, Peiman
AU - Irwin, David
AU - Karam, Jose A.
AU - Matin, Surena F.
AU - Stafford, Jason
AU - Ahrar, Kamran
N1 - Publisher Copyright:
© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024.
PY - 2024
Y1 - 2024
N2 - Objectives: To evaluate the technical success and outcomes of renal biopsies performed under magnetic resonance imaging (MRI) using a closed-bore, 1.5-Tesla MRI unit. Materials and methods: We retrospectively reviewed our institutional biopsy database and included 150 consecutive MRI-guided biopsies for renal masses between November 2007 and March 2020. We recorded age, sex, BMI, tumor characteristics, RENAL nephrometry score, MRI scan sequence, biopsy technique, complications, diagnostic yield, pathologic outcome, and follow-up imaging. Univariate logistic regression was used to assess the association between different parameters and the development of complications. McNemar’s test was used to assess the association between paired diagnostic yield measurements for fine-needle aspiration and core samples. Results: A total of 150 biopsies for 150 lesions were performed in 150 patients. The median tumor size was 2.7 cm. The median BMI was 28.3. The lesions were solid, partially necrotic/cystic, and predominantly cystic in 137, eight, and five patients, respectively. Image guidance using fat saturation steady-state free precession sequence was recorded in 95% of the biopsy procedures. Samples were obtained using both fine-needle aspiration (FNA) and cores in 99 patients (66%), cores only in 40 (26%), and FNA only in three (2%). Tissue sampling was diagnostic in 144 (96%) lesions. No major complication developed following any of the biopsy procedures. The median follow-up imaging duration was 8 years and none of the patients developed biopsy-related long-term complication or tumor seeding. Conclusions: MRI-guided renal biopsy is safe and effective, with high diagnostic yield and no major complications. Clinical relevance statement: Image-guided renal biopsy is safe and effective, and should be included in the management algorithm of patients with renal masses. Core biopsy is recommended. Key Points: • MRI-guided biopsy is a safe and effective technique for sampling of renal lesions. • MRI-guided biopsy has high diagnostic yield with no major complications. • Percutaneous image-guided biopsy plays a key role in the management of patients with renal masses.
AB - Objectives: To evaluate the technical success and outcomes of renal biopsies performed under magnetic resonance imaging (MRI) using a closed-bore, 1.5-Tesla MRI unit. Materials and methods: We retrospectively reviewed our institutional biopsy database and included 150 consecutive MRI-guided biopsies for renal masses between November 2007 and March 2020. We recorded age, sex, BMI, tumor characteristics, RENAL nephrometry score, MRI scan sequence, biopsy technique, complications, diagnostic yield, pathologic outcome, and follow-up imaging. Univariate logistic regression was used to assess the association between different parameters and the development of complications. McNemar’s test was used to assess the association between paired diagnostic yield measurements for fine-needle aspiration and core samples. Results: A total of 150 biopsies for 150 lesions were performed in 150 patients. The median tumor size was 2.7 cm. The median BMI was 28.3. The lesions were solid, partially necrotic/cystic, and predominantly cystic in 137, eight, and five patients, respectively. Image guidance using fat saturation steady-state free precession sequence was recorded in 95% of the biopsy procedures. Samples were obtained using both fine-needle aspiration (FNA) and cores in 99 patients (66%), cores only in 40 (26%), and FNA only in three (2%). Tissue sampling was diagnostic in 144 (96%) lesions. No major complication developed following any of the biopsy procedures. The median follow-up imaging duration was 8 years and none of the patients developed biopsy-related long-term complication or tumor seeding. Conclusions: MRI-guided renal biopsy is safe and effective, with high diagnostic yield and no major complications. Clinical relevance statement: Image-guided renal biopsy is safe and effective, and should be included in the management algorithm of patients with renal masses. Core biopsy is recommended. Key Points: • MRI-guided biopsy is a safe and effective technique for sampling of renal lesions. • MRI-guided biopsy has high diagnostic yield with no major complications. • Percutaneous image-guided biopsy plays a key role in the management of patients with renal masses.
KW - Biopsy
KW - Magnetic resonance imaging
KW - Renal
UR - http://www.scopus.com/inward/record.url?scp=85185933266&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85185933266&partnerID=8YFLogxK
U2 - 10.1007/s00330-024-10656-0
DO - 10.1007/s00330-024-10656-0
M3 - Article
C2 - 38400904
AN - SCOPUS:85185933266
SN - 0938-7994
JO - European Radiology
JF - European Radiology
ER -